{"id":1927,"date":"2023-03-16T12:50:02","date_gmt":"2023-03-16T12:50:02","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=1927"},"modified":"2023-03-16T12:50:03","modified_gmt":"2023-03-16T12:50:03","slug":"evergreen-theragnostics-raises-15m-in-series-b-funding-round","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/","title":{"rendered":"Evergreen Theragnostics Raises $15M in Series B Funding Round."},"content":{"rendered":"\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-178.png\" alt=\"\" class=\"wp-image-1928\" width=\"156\" height=\"156\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-178.png 200w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-178-150x150.png 150w\" sizes=\"(max-width: 156px) 100vw, 156px\" \/><\/figure>\n\n\n\n<p>Springfield, New Jersey &#8211; <a href=\"https:\/\/evergreentgn.com\/\">Evergreen Theragnostics<\/a>, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased to announce that it has raised $15 million in a Series B funding round. The financing was led by some prominent investors and was supported by the company\u2019s founder James Cook.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-179.png\" alt=\"\" class=\"wp-image-1929\" width=\"741\" height=\"496\" srcset=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-179.png 584w, https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/image-179-300x201.png 300w\" sizes=\"(max-width: 741px) 100vw, 741px\" \/><\/figure>\n\n\n\n<p>Founded in 2019, Evergreen Theragnostics has established itself as an industry leader in theragnostic radiopharmaceutical commercialization, manufacturing process development, and regulatory affairs management. This strategic injection of capital will allow the company to accelerate its research and development efforts while expanding its operations globally.\u00a0<\/p>\n\n\n\n<p>Commenting on the successful fundraising, <a href=\"https:\/\/www.linkedin.com\/in\/james-cook-91a0002\/\">James Cook<\/a> stated: \u201cThis investment will enable us to continue our mission of providing customers with high-quality radiopharmaceutical products at competitive prices. We are excited about the possibilities this funding round brings and are confident that it will help us expand our customer base and extend our reach across the globe.&#8221;<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/Evergreen-Theragnostics-team-photo_11zon.png\" alt=\"\" \/><\/figure>\n\n\n\n<p>With this new investment, Evergreen Theragnostics is poised to make significant strides toward achieving its goal of becoming one of the leading CDMOs in the pharmaceutical manufacturing industry.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Springfield, New Jersey &#8211; Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased to announce that it has raised $15 million in a Series B funding round. The financing was led by some prominent investors and was supported by the company\u2019s founder James Cook. Founded in 2019, Evergreen Theragnostics has established [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":1933,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v20.2.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Evergreen Theragnostics Raises $15M in Series B Funding Round. - Founder Lodge Latest News Evergreen Theragnostics Raises $15M in Series B Funding Round.<\/title>\n<meta name=\"description\" content=\"Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased to announce that it has raised $15 million in a Series B funding round. The financing was led by some prominent investors and was supported by the company\u2019s founder James Cook.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evergreen Theragnostics Raises $15M in Series B Funding Round. - Founder Lodge Latest News Evergreen Theragnostics Raises $15M in Series B Funding Round.\" \/>\n<meta property=\"og:description\" content=\"Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased to announce that it has raised $15 million in a Series B funding round. The financing was led by some prominent investors and was supported by the company\u2019s founder James Cook.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-16T12:50:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-16T12:50:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/Evergreen-Theragnostics_11zon.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"556\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ucheezuma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ucheezuma\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/\"},\"author\":{\"name\":\"ucheezuma\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\"},\"headline\":\"Evergreen Theragnostics Raises $15M in Series B Funding Round.\",\"datePublished\":\"2023-03-16T12:50:02+00:00\",\"dateModified\":\"2023-03-16T12:50:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/\"},\"wordCount\":184,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/\",\"name\":\"Evergreen Theragnostics Raises $15M in Series B Funding Round. - Founder Lodge Latest News Evergreen Theragnostics Raises $15M in Series B Funding Round.\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-03-16T12:50:02+00:00\",\"dateModified\":\"2023-03-16T12:50:03+00:00\",\"description\":\"Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased to announce that it has raised $15 million in a Series B funding round. The financing was led by some prominent investors and was supported by the company\u2019s founder James Cook.\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evergreen Theragnostics Raises $15M in Series B Funding Round.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3\",\"name\":\"ucheezuma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g\",\"caption\":\"ucheezuma\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evergreen Theragnostics Raises $15M in Series B Funding Round. - Founder Lodge Latest News Evergreen Theragnostics Raises $15M in Series B Funding Round.","description":"Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased to announce that it has raised $15 million in a Series B funding round. The financing was led by some prominent investors and was supported by the company\u2019s founder James Cook.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/","og_locale":"en_US","og_type":"article","og_title":"Evergreen Theragnostics Raises $15M in Series B Funding Round. - Founder Lodge Latest News Evergreen Theragnostics Raises $15M in Series B Funding Round.","og_description":"Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased to announce that it has raised $15 million in a Series B funding round. The financing was led by some prominent investors and was supported by the company\u2019s founder James Cook.","og_url":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-03-16T12:50:02+00:00","article_modified_time":"2023-03-16T12:50:03+00:00","og_image":[{"width":1024,"height":556,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/03\/Evergreen-Theragnostics_11zon.png","type":"image\/png"}],"author":"ucheezuma","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ucheezuma","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/"},"author":{"name":"ucheezuma","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3"},"headline":"Evergreen Theragnostics Raises $15M in Series B Funding Round.","datePublished":"2023-03-16T12:50:02+00:00","dateModified":"2023-03-16T12:50:03+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/"},"wordCount":184,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/","url":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/","name":"Evergreen Theragnostics Raises $15M in Series B Funding Round. - Founder Lodge Latest News Evergreen Theragnostics Raises $15M in Series B Funding Round.","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-03-16T12:50:02+00:00","dateModified":"2023-03-16T12:50:03+00:00","description":"Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased Springfield, New Jersey - Evergreen Theragnostics, a US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO), is pleased to announce that it has raised $15 million in a Series B funding round. The financing was led by some prominent investors and was supported by the company\u2019s founder James Cook.","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/evergreen-theragnostics-raises-15m-in-series-b-funding-round\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Evergreen Theragnostics Raises $15M in Series B Funding Round."}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who&#039;s raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/2854d3c2f2bb3f7ff9ae13c649048af3","name":"ucheezuma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff09ab70d3a1229d484147623818e0af?s=96&d=mm&r=g","caption":"ucheezuma"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/ucheezuma\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1927"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=1927"}],"version-history":[{"count":1,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1927\/revisions"}],"predecessor-version":[{"id":1934,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/1927\/revisions\/1934"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/1933"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=1927"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=1927"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=1927"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}